Cynata Announces Ethics Approval and Expedited Regulatory Pathway for Phase 3 Osteoarthritis Clinical Trial

    NEXT STORY
    PRA Health Sciences ready to navigate RACE Act requirements for pediatric oncology
    PREV STORY
    Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Nanobiotix announces submission for first market approval of lead product NBTXR3 in Europe

          CE Mark filing based on current level of scientific and clinical evidence Phase II/III ...

    author_avatar
    NASDAQ Market News

    Celyad Appoints Dr. Richard Mountfield as Vice-President of Global Regulatory Affairs

    MONT-SAINT-GUIBERT, Belgium, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a ...

    author_avatar
    NASDAQ Market News

    European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer

    author_avatar
    NASDAQ Market News